ACE and Hand-foot syndrome: Concerning the availability of essential drugs to manage CVD (Figure 3c), 0.1% of HFs have angiotensin-converting enzyme inhibitors, 0.1% have hydrochlorothiazide, 100% have calcic inhalers, 0.1% have beta-blockers, and 0.1% have aspirin.